Likewise, glutaminolysis was used as an alternative pathway, evidenced by upregulation of glutamate oxidation-regulating genes (GLUD1, DGLUCY) in COVID-19(+) CD8+TM (Fig. 7a). This evidence concerns the gene CD8A and COVID-19.